tyrosine has been researched along with Huntington Disease in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Bandookwala, M; Sengupta, P | 1 |
| Burman, J; Emami Khoonsari, P; Herman, S; Kultima, K; Landtblom, AM; Niemelä, V; Nyholm, D; Spjuth, O; Sundblom, J | 1 |
| Jia, JP; Li, D; Tang, Y; Xu, EH | 1 |
| Agüera, E; Cruz-Guerrero, A; Fernández-Bolaños, R; Gascón-Luna, F; Sánchez, FM; Sánchez-López, F; Tasset, I; Túnez, I | 1 |
| Apostol, BL; Bates, GP; Cha, JH; DeJohn, MM; Dunah, AW; Farrell, LA; Luthi-Carter, R; Standaert, DG; Thompson, LM; Young, AB | 1 |
| Kim, SU; McLarnon, JG; Ryu, JK | 1 |
| Choi, DK; Heinecke, JW; Jackson-Lewis, V; Pennathur, S; Perier, C; Przedborski, S; Teismann, P; Tieu, K; Vila, M; Vonsattel, JP; Wu, DC | 1 |
| Ali, SF; Galván-Arzate, S; González-Cortés, C; Medina-Campos, ON; Pedraza-Chaverrí, J; Pérez-De La Cruz, V; Pérez-Severiano, F; Santamaría, A | 1 |
| Beal, MF; Galpern, WR; Isacson, O; Matthews, RT | 1 |
| Beal, MF; Ferrante, RJ; Jenkins, BG; Kaddurah-Daouk, R; Matthews, RT; Rosen, BR; Yang, L | 1 |
| Andersen, JK; Andreassen, OA; Beal, MF; Bogdanov, M; Dedeoglu, A; Ferrante, RJ; Jiang, D; Klivenyi, P; Lancelot, E; Mueller, G | 1 |
| Abeles, I; Covault, J; Deckel, AW; Gary, KA; Sasso, D; Schmerler, N; Volmer, P; Watts, D; Weiner, R; Yan, Z | 1 |
| Deckel, AW; Freitas, R; Gary, KA; Gordinier, A; Kuwada, C; Nuttal, D; Tang, V | 1 |
| Gerbeaux, J; Labrune, B; Tournier, G | 1 |
| Beal, MF; Bird, ED; Matson, WR; Milbury, P; Ogawa, T; Ryan, EA; Storey, E | 1 |
| Beal, MF; Bird, ED; Gamache, PH; Matson, WR; Swartz, KJ | 1 |
| Baskin, F; Rosenberg, RN | 1 |
| Cotzias, GC; Gellene, R; Papavasiliou, PS | 1 |
| Diamond, S; Hansen, S; Perry, TL; Stedman, D | 1 |
| Insarova, NG | 1 |
| Ottosson, JO; Rapp, W | 1 |
| Hansen, S; Lesk, D; Perry, TL | 1 |
| Davidson, D; Magill, BE; Murray, LG; Pullar, IA; Wilson, H; Yates, CM | 1 |
| Constantinidis, J | 1 |
2 review(s) available for tyrosine and Huntington Disease
| Article | Year |
|---|---|
3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Biomarkers; Humans; Huntington Disease; Parkinson Disease; Prion Diseases; Tyrosine | 2020 |
[Pediatrics in 1976].
Topics: Adolescent; alpha 1-Antitrypsin Deficiency; Body Weight; Carcinoma, Hepatocellular; Catheterization; Child; Child, Preschool; Glycine max; Haemophilus Infections; Humans; Huntington Disease; Infant; Infant, Newborn; Levamisole; Liver Neoplasms; Malabsorption Syndromes; Mucocutaneous Lymph Node Syndrome; Nitrites; Obesity; Pediatrics; Pericarditis; Sepsis; Splenectomy; Tyrosine; Urinary Tract Infections | 1977 |
1 trial(s) available for tyrosine and Huntington Disease
| Article | Year |
|---|---|
Modification of Parkinsonism--chronic treatment with L-dopa.
Topics: Adult; Aged; Agranulocytosis; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Blood-Brain Barrier; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Feeding and Eating Disorders; Female; Humans; Huntington Disease; Male; Manganese; Mental Processes; Methyldopa; Middle Aged; Movement Disorders; Nausea; Neurologic Manifestations; Parkinson Disease; Phenylacetates; Placebos; Thyroid Function Tests; Tyrosine; Vomiting | 1969 |
21 other study(ies) available for tyrosine and Huntington Disease
| Article | Year |
|---|---|
Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects.
Topics: Adult; Aged; Biomarkers; Dopamine; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Phenylalanine; Thyroxine; Tyrosine | 2019 |
Polymorphism of HD and UCHL-1 genes in Huntington's disease.
Topics: Adult; Age of Onset; Aged; Alleles; Chi-Square Distribution; Family Health; Female; Gene Frequency; Genotype; Humans; Huntington Disease; Male; Middle Aged; Polymorphism, Genetic; Serine; Trinucleotide Repeat Expansion; Tyrosine; Ubiquitin Thiolesterase; Young Adult | 2009 |
NGF and nitrosative stress in patients with Huntington's disease.
Topics: Adult; Biomarkers; Female; Humans; Huntington Disease; Male; Middle Aged; Nerve Growth Factor; Nitrosation; Severity of Illness Index; Tyrosine; Young Adult | 2012 |
Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation.
Topics: Actinin; Animals; Brain; Cell Membrane; Disease Models, Animal; Disks Large Homolog 4 Protein; Guanylate Kinases; Huntingtin Protein; Huntington Disease; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Phosphorylation; Protein Structure, Tertiary; Protein Subunits; Protein Transport; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Tyrosine | 2003 |
Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
Topics: Animals; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Guanidines; Huntington Disease; Lactic Acid; Male; Neostriatum; Neuroglia; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Tyrosine | 2004 |
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amyotrophic Lateral Sclerosis; Animals; Brain; Corpus Striatum; Dopamine; Drug Evaluation, Preclinical; Enzyme Induction; Humans; Huntington Disease; Hypochlorous Acid; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine | 2005 |
Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Topics: Analysis of Variance; Animals; Behavior, Animal; Blotting, Southern; Brain Injuries; Caspase 3; Caspases; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electrophoresis, Agar Gel; gamma-Aminobutyric Acid; Huntington Disease; Lipid Peroxidation; Male; Mitochondria; Motor Activity; Nitric Oxide Synthase; Peroxynitrous Acid; Porphyrins; Quinolinic Acids; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Rotarod Performance Test; Superoxide Dismutase; Synaptic Vesicles; Synaptosomes; Tyrosine | 2005 |
NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Huntington Disease; Male; Nerve Growth Factors; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Tyrosine | 1996 |
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Antineoplastic Agents; Creatine; Creatinine; Disease Models, Animal; Energy Metabolism; Free Radicals; Huntington Disease; Lactates; Male; Malonates; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley; Tyrosine | 1998 |
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catechols; Convulsants; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Female; Free Radicals; Glutathione; Glutathione Peroxidase; Heterozygote; Homovanillic Acid; Homozygote; Huntington Disease; Male; Malonates; Mice; Mice, Inbred Strains; Mice, Knockout; MPTP Poisoning; Nitro Compounds; Oxidative Stress; Parkinson Disease, Secondary; Propionates; Tyrosine | 2000 |
Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice.
Topics: Animals; Arginine; Blood Glucose; Brain; Cerebrovascular Circulation; Diet; Huntington Disease; Mice; Mice, Transgenic; Movement Disorders; Time Factors; Tyrosine; Weight Loss | 2000 |
Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Calcium-Calmodulin-Dependent Protein Kinases; Disease Models, Animal; Enzyme Inhibitors; Female; Huntington Disease; Immunohistochemistry; Male; Mice; Mice, Transgenic; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Tyrosine | 2001 |
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Energy Metabolism; Free Radicals; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Middle Aged; Parkinson Disease; Purines; Tryptophan; Tyrosine | 1992 |
Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.
Topics: Aged; Autopsy; Corpus Striatum; Female; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Male; Middle Aged; Putamen; Reference Values; Tryptophan; Tyrosine | 1990 |
Dopa as an antimetabolite in Huntington's disease.
Topics: Acylation; Adult; Amino Acyl-tRNA Synthetases; Antimetabolites; Basal Ganglia; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease; Middle Aged; Molecular Conformation; Neurons; Proteins; RNA, Transfer; Tyrosine; Tyrosine 3-Monooxygenase | 1973 |
Plasma-aminoacid levels in Huntington's chorea.
Topics: Adult; Alanine; Amino Acids; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine; Valine | 1969 |
[Urinary excretion of free amino acids in families of patints with Huntington's chorea].
Topics: Adult; Aged; Alanine; Amino Acids; Chromatography, Paper; Female; Glutamates; Humans; Huntington Disease; Male; Middle Aged; Spectrophotometry; Tyrosine | 1969 |
Serum levels of phenylalanine and tyrosine in Huntington's chorea.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Body Weight; Dopamine; Female; Humans; Huntington Disease; Male; Middle Aged; Norepinephrine; Parasympatholytics; Phenylalanine; Psychotic Disorders; Reserpine; Schizophrenia; Tryptophan; Tyrosine | 1971 |
[Plasma amino acid levels in children of patients with Huntington's chorea].
Topics: Adolescent; Adult; Alanine; Amino Acids; Child; Child, Preschool; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine | 1972 |
Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington's chorea.
Topics: Acid Phosphatase; Adult; Aged; Amines; Amino Acids; Blood Proteins; Cerebrospinal Fluid Proteins; Dopamine; Female; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lysosomes; Male; Middle Aged; Phenylacetates; Serotonin; Sulfatases; Tryptophan; Tyrosine | 1973 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine | 1972 |